Crescita Therapeutics, Inc.

Crescita Therapeutics, Inc. - Enterprise Valueverified

CRRTF

Price:

$0.5587

Market Cap:

$14.71M

Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers and DuraPeel that supports the development of patented formulations to facilitate the delivery of active ingredients into or through the skin. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermat...[Read more]

Industry

Medical - Pharmaceuticals

IPO Date

2016-04-11

Stock Exchange

OTC

Ticker

CRRTF

The Enterprise Value as of July 2026 (TTM) for Crescita Therapeutics, Inc. (CRRTF) is 8.50M

According to Crescita Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 8.50M. This represents a change of 204.22% compared to the average of 2.79M of the last 4 quarters.

Crescita Therapeutics, Inc. (CRRTF) Historical Enterprise Value (quarterly & annually)

How has CRRTF Enterprise Value performed in the past?

The mean historical Enterprise Value of Crescita Therapeutics, Inc. over the last ten years is 5.21M. The current 8.50M Enterprise Value has changed 16.22% with respect to the historical average. Over the past ten years (40 quarters), CRRTF's Enterprise Value was at its highest in in the March 2017 quarter at 17.33M. The Enterprise Value was at its lowest in in the June 2016 quarter at -12394844.10.

Quarterly (TTM)
Annual

Average

5.21M

Median

4.65M

Minimum

805.95K

Maximum

12.20M

Crescita Therapeutics, Inc. (CRRTF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Crescita Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 256.08%

Maximum Annual Enterprise Value = 12.20M

Minimum Annual Increase = -87.99%

Minimum Annual Enterprise Value = 805.95K

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025805.95K-70.58%
20242.74M52.67%
20231.79M-74.48%
20227.03M39.84%
20215.03M256.08%
20201.41M-87.99%
201911.76M156.15%
20184.59M-2.67%
20174.72M-61.35%
201612.20M-24.87%

Crescita Therapeutics, Inc. (CRRTF) Average Enterprise Value

How has CRRTF Enterprise Value performed in the past?

The current Enterprise Value of Crescita Therapeutics, Inc. (CRRTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

1.78M

5-year avg

3.48M

10-year avg

5.21M

Crescita Therapeutics, Inc. (CRRTF) Enterprise Value vs. Peers

How is CRRTF’s Enterprise Value compared to its peers?

Crescita Therapeutics, Inc.’s Enterprise Value is greater than Ayurcann Holdings Corp. (1.52M), greater than Delivra Health Brands Inc. (2.66M), less than Ayr Wellness Inc. (599.27M), less than Christina Lake Cannabis Corp. (13.28M), greater than CV Sciences, Inc. (5.26M), greater than Bright Green Corporation (1.94M), greater than CanaFarma Hemp Products Corp. (-986333.00), greater than Healthy Extracts Inc. (5.56M), less than Univec, Inc. (9.53M), less than Tristar Wellness Solutions Inc. (9.40M),

Build a custom stock screener for Crescita Therapeutics, Inc. (CRRTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Crescita Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Crescita Therapeutics, Inc. (CRRTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Crescita Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Crescita Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Crescita Therapeutics, Inc. (CRRTF)?

What is the 3-year average Enterprise Value for Crescita Therapeutics, Inc. (CRRTF)?

What is the 5-year average Enterprise Value for Crescita Therapeutics, Inc. (CRRTF)?

How does the current Enterprise Value for Crescita Therapeutics, Inc. (CRRTF) compare to its historical average?